Evidence map›Paper›PMID 28067877›Full record

Trial reportBone marrow transplantation2017

Dismal outcome of allogeneic hematopoietic stem cell transplantation for relapsed adult T-cell leukemia/lymphoma, a Japanese nation-wide study.

H Fujiwara, S Fuji, A Wake, K Kato, Y Takatsuka, T Fukuda, J Taguchi, N Uchida, T Miyamoto, M Hidaka and 8 more

Open access · bronzeAbstract readClinical TrialMulticenter Study
PubMed Publisher
In one paragraph

Trial report in Bone marrow transplantation, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Revised Adult T-Cell Leukemia-Lymphoma International Consensus Meeting Report.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2019
    Guideline
  3. Trial
  4. MogamulizumabHaematologica · 2019
    Trial
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Observational
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 12 institutions in 1 country.

H FujiwaraFirst Department of Internal Medicine, Ehime University Hospital, Ehime, Japan.
S FujiDepartment of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
A WakeDepartment of Hematology, Toranomon Hospital Kajigaya, Kanagawa, Japan.
K KatoDepartment of Hematology and Oncology, Kyushu University Hospital, Fukuoka, Japan.
Y TakatsukaDepartment of Hematology, Imamura Bun-in Hospital, Kagoshima, Japan.
T FukudaDepartment of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
J TaguchiDepartment of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Nagasaki University Hospital, Nagasaki, Japan.
N UchidaDepartment of Hematology, Toranomon Hospital, Tokyo, Japan.
T MiyamotoDepartment of Hematology and Oncology, Kyushu University Hospital, Fukuoka, Japan.
M HidakaDepartment of Hematology, National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan.
Y MiyazakiDepartment of Hematology, Oita Prefecture Hospital, Oita, Japan.
T TomoyoseSecond Department of Internal Medicine, University Hospital, University of the Ryukyus, Okinawa, Japan.
M OnizukaDepartment of Hematology and Oncology, Tokai University School of Medicine, Kanagawa, Japan.
M TakanashiBlood Service Headquarters, Japanese Red Cross Society, Tokyo, Japan.
T IchinoheDepartment of Hematology and Oncology, Hiroshima University Hospital, Hiroshima, Japan.
Y AtsutaJapanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan.
A UtsunomiyaDepartment of Hematology, Imamura Bun-in Hospital, Kagoshima, Japan.
ATL Working Group of the Japan Society for Hematopoietic Cell Transplantation
Imamura Hospital · JPKyushu University Hospital · JPToranomon Hospital · JPEhime University Hospital · JPHiroshima University Hospital · JPJapanese Red Cross Society, Japan · JPKumamoto Medical Center · JPNagasaki University Hospital · JPOita Prefectural Hospital · JPThe Japanese Data Center for Hematopoietic Cell Transplantation · JPTokai University · JPUniversity of the Ryukyus · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hematopoietic Stem Cell TransplantationAdultAllograftsFemaleHumansJapanLeukemia-Lymphoma, Adult T-CellMaleMiddle Aged

Identifiers

PMID28067877
OpenAlexW2569436233

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.